Skip to main content
. 2021 Nov 6;9(31):9469–9480. doi: 10.12998/wjcc.v9.i31.9469

Table 2.

Distribution of symptoms in the total cohort and by faecal elastase-1 result, and results from the univariable logistic regression analysis.

Symptom
Total cohort, n (%)
FE1 ≥ 200 μg/g, n (%)
FE1 < 200 μg/g, n (%)
OR (95%CI)
P value
Abdominal pain 567 (55.2) 476 (56.3) 91 (50.0) 0.77 (0.56-1.06) 0.112
Diarrhoea 671 (65.3) 545 (64.5) 126 (69.2) 1.23 (0.87-1.74) 0.231
Weight loss 392 (38.2) 308 (36.4) 84 (46.2) 1.49 (1.08-2.06) 0.015
Bloating 263 (25.6) 226 (26.7) 37 (20.3) 0.70 (0.47-1.03) 0.072
Nausea and vomiting 129 (12.6) 106 (12.5) 23 (12.6) 1.01 (0.62-1.63) 0.973
Steatorrhoea 95 (9.3) 64 (7.6) 31 (17.0) 2.51 (1.58-3.98) < 0.001
Dyspepsia 86 (8.4) 71 (8.4) 15 (8.2) 0.98 (0.55-1.75) 0.943
Flatulence 61 (5.9) 55 (6.5) 6 (3.3) 0.49 (0.21-1.16) 0.103
Fatigue 21 (2.0) 19 (2.3) 2 (1.1) 0.48 (0.11-2.09) 0.331

FE1: Faecal elastase-1.